Chlorella for Hypertension

Verdict: Weak, inconsistent evidence for blood pressure

Chlorella may modestly lower blood pressure, but the evidence is inconsistent and the effect is small and of uncertain clinical importance. It is not a substitute for proven treatments, and no health authority or clinic endorses it for hypertension.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade is weak because the trial evidence points in conflicting directions. Two meta-analyses found a statistically significant but small drop in systolic blood pressure: roughly 4.5 mmHg in a 2018 pooled analysis of 19 trials (PMID 29037431) and about 3.7 mmHg in a 2025 GRADE-assessed review (PMID S2211926425003923), with only borderline effects on diastolic pressure.

However, two 2025 meta-analyses substantially weaken that signal. One found chlorella had a neutral, non-significant effect on blood pressure, with the benefit attributable to spirulina, and it carried an industry conflict of interest (PMID 40289965). A broader edible-algae analysis of 1,583 people likewise showed the blood-pressure reduction was driven by spirulina, with chlorella not flagged as an independent contributor (PMID 40726022). An early 2002 pilot found only 25% of patients responded (PMID 12495586).

Authoritative backing is absent. No major clinic or society, Mayo, Cleveland Clinic, Harvard, or hypertension specialty bodies, takes any position on chlorella for blood pressure. The US FDA has acted against products claiming chlorella reduces high blood pressure, and the EU EFSA rejected related health claims. Chlorella is also high in vitamin K and can interfere with the blood thinner warfarin, a concern for many people with hypertension.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.47
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
79%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.472
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Effect of Chlorella supplementation on cardiovascular risk factors: A meta-analysis of randomized controlled trials
PMID: 29037431 2018 統合分析 n = 797
Finding: Across 19 RCTs, Chlorella significantly reduced SBP (WMD -4.51 mmHg, 95% CI -6.53 to -2.48, p<0.001) and DBP (WMD -1.64 mmHg, 95% CI -3.28 to -0.01, p=0.049); DBP effect borderline significant.
Effect size: WMD SBP -4.51 mmHg; DBP -1.64 mmHg
View on PubMed
Chlorella supplementation diminishes cardiovascular risk factors in adults: A GRADE-assessed systematic review and meta-analyses of randomized clinical trials
PMID: 2025 統合分析
— See PubMed for details
View on PubMed
The Role of Chlorella and Spirulina as Adjuvants of Cardiovascular Risk Factor Control: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
PMID: 40289965 2025 統合分析
Finding: Chlorella showed a neutral effect on blood pressure with no significant changes; only Spirulina (separate analysis) significantly reduced DBP. Authors recommend further trials.
Mixed funding Effect size: Chlorella: BP change not significant (neutral)
View on PubMed
Edible Algae Reduce Blood Pressure in Humans: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
PMID: 40726022 2025 統合分析 n = 1,583
Finding: Across 29 RCTs of edible algae, pooled SBP fell 2.05 mmHg (95% CI -3.80 to -0.31) and DBP 1.87 mmHg (95% CI -3.10 to -0.64); the effect was driven mainly by Spirulina (-5.28/-3.56 mmHg), with Chlorella not highlighted as a significant individual contributor.
Effect size: Pooled algae WMD SBP -2.05 mmHg; DBP -1.87 mmHg (Spirulina-driven)
View on PubMed
Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension
PMID: 12495586 2002 RCT (open-label) n = 24
Finding: Heterogeneous response: only 25% (6 of 24) reached DBP goal <90 mmHg after 2 months; non-responders' BP did not rise above washout values. Small uncontrolled pilot, low quality.
🟠 Limited quality Effect size: 25% responder rate; mean sitting DBP 96.5 +/- 6.6 mmHg post-treatment
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
Consumers who use OTC chelation products for detoxification are exposed to all the risks associated with chelation. These risks are not acceptable, given that there is no proof that 'detoxification' using these products is effective to prevent or treat any condition or disease. source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
綠藻(小球藻)產品應符合衛福部「可供食用藻類衛生標準」,並就重金屬(砷、鉛、鎘、汞)、微囊藻毒素、神經毒素(BMAA)、農藥、塑化劑及微生物等項目進行檢驗。 source↗
L5a NIH Office of Dietary Supplements
Cautious
L5e Specialty Society (condition-mapped)
Not addressed
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-hypertension-INT-chlorella-001 繁體中文版 →